NCT00998946 2021-11-05Study of Pralatrexate to Treat Participants With Relapsed or Refractory B-cell Non-Hodgkin's LymphomaSpectrum Pharmaceuticals, IncPhase 2 Completed29 enrolled 8 charts
NCT00481871 2020-01-07Study of Pralatrexate & Gemcitabine With B12 & Folic Acid to Treat Relapsed/Refractory Lymphoproliferative MalignanciesAcrotech Biopharma Inc.Phase 1/2 Completed119 enrolled 13 charts